FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Adalimumab (Humira) Pre-filled Syringe
Status: Discontinuation
»Therapeutic Categories: Dermatology; Gastroenterology; Ophthalmology; Rheumatology

Expand all

Abbvie (New 07/27/2020)

Company Contact Information:
800-255-5162

Presentation Posting Date Related Information
10 mg/0.2 mL pre-filled syringe (NDC 0074-6347-02) 07/27/2020 The company has discontinued manufacture of these products based on a market assessment and product demand.
20 mg/0.4 mL pre-filled syringe (NDC 0074-9374-02) 07/27/2020 The company has discontinued manufacture of these products based on a market assessment and product demand.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English